Imatinib Mesylate (STI 571) – A New Oral Target Therapy For Chronic Myelogenous Leukemia (CML)

by Ladislav Chrobák, Jaroslava Voglová
Published 2003-01-01

Improvement of Anaemia in Patients with Primary Myelofibrosis by Low-Dose Thalidomide and Prednisone

by Petra Bělohlávková, Vladimír Maisnar, Jaroslava Voglová, Tomáš Buchler, Pavel Žák
Published 2016-08-01

The Multidrug Resistance and Apoptosis Evaluation in Acute Myeloid Leukemia Cells After the In Vitro Doxorubicin Treatment

by Karolína Jankovičová, Jan Krejsek, Otakar Kopecký, Jaroslava Voglová, Zuzana Škrabková, Jakub Novosad
Published 2004-01-01

The Effects of Subchronical Exposure to SO2 on Biochemical and Hematological Parameters in Guinea Pigs

by Jana Suchánková, Peter Višňovský, Vladimír Geršl, Zdeněk Fiala, Yvona Mazurová, Vladimír Palička, Jaroslava Vávrová, Jaroslava Voglová
Published 1997-01-01

Effects of Repeated Administration of Dithiol Chelating Agent - Sodium 2,3-Dimercapto-1-propanesulphonate (DMPS) - On Biochemical and Haematological Parameters in Rabbits

by Vladimír Geršl, Radomír Hrdina, Jaroslava Vávrová, Magdalena Holečková, Vladimír Palička, Jaroslava Voglová, Yvona Mazurová, Jiří Bajgar
Published 1997-01-01

The significance of enzyme and transporter polymorphisms for imatinib plasma levels and achieving an optimal response in chronic myeloid leukemia patients

by Petra Belohlavkova, Filip Vrbacky, Jaroslava Voglova, Zdenek Racil, Daniela Zackova, Katerina Hrochova, Jana Malakova, Jiri Mayer, Pavel Zak
Published 2018-02-01

Chronic myeloid leukemia patients in prolonged remission following interferon-α monotherapy have distinct cytokine and oligoclonal lymphocyte profile.

by Anna Kreutzman, Peter Rohon, Edgar Faber, Karel Indrak, Vesa Juvonen, Veli Kairisto, Jaroslava Voglová, Marjatta Sinisalo, Emília Flochová, Jukka Vakkila, Petteri Arstila, Kimmo Porkka, Satu Mustjoki
Published 2011-01-01